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Abstract 
Buccal administration of drugs which exhibit a low oral bioavailability is a useful method to achieve higher 
bioavailability. The objective of present research work is to design and evaluate the prolong release bioadhesive 
buccal tablet of Aminophylline with goal to increase the bioavalability, reduce dosing frequency and improve 
patient compliance. Aminophylline is ethylenediamine salt of theophylline. Buccal tablets of aminophylline were 
prepared by direct compression using different  bioadhesive polymers such as HPMC K4M and Carbopol 934-P. 
The prepared tablets were subjected to post friability, Hardness thickness, weight variation, drug content and 
swelling index, bioadhesive strength, In-vitro drug release. 
Keywords:  Aminophylline, HPMC, direct compression method, Swelling index, in-vitro drug release. 
 
1. Introduction 
Sublingual tablet and chewing gum are widely used systems but upon their administration a large proportion of 
the administered dose can be swallowed before being absorbed (Benowitz  & Savanapridi 1987). It is proposed 
that a sustained release bioadhesive tablet can help to avoid this undesirable effect and also exhibit a longer 
duration of action. Buccal delivery of drug, as an alternative to the oral route of drug administration, is a subject 
of growing interest because of its numerous advantages such as good accessibility, robustness of epithelium, 
facile removal of dosage form in case of need, relatively low enzymatic activity, prevent drug degradation in 
gastrointestinal tract and avoid hepatic first-pass metabolismIn the last decade considerable interest has been 
focused on buccal drug delivery systems(Burgalassi & Rassing  1996, Ghosh & Pfister  2005, Bruschi & Freitas 
2005, Madhav & Singh 2009) using the oral mucosal cavity as an attractive administration route. Several 
advantages (Mizrahi & Domb 2008) such as relative permeability, robustness and short recovery after stress or 
damage are related to mucous membrane. However, oral mucosa has been considered advantageous to the oral 
route because they bypass the hepatic first-pass effect and pre-systemic metabolism into the gastrointestinal track. 
Furthermore, drug absorption can be discontinued in the case of toxic effects by discharging the formulation 
from the buccal cavity (Miller & Johnston 2005). Bioadhesive formulations have been developed to enhance the 
bioavailability (Wong & Peh 1999, Choi & Kim2000) of drugs that undergo substantial first-pass hepatic effect 
and to control the drug release to a constant rate (Choi & Kim 2000). Aminophylline is ethylenediamine salt of 
theophylline. Theophylline stimulates the Central Nervous Systeme, skeletal muscles and cardiac muscle. It also 
relaxes certain smooth muscles in the bronchi through PDE3 inhibition, produces diuresis, and causes an 
increase in gastric secretion. 
 
2. Materials and Method 
2.1. Materials 
Aminophylline was received as gift sample from Sandoz Pharma Ltd, Mumbai. Hydroxypropyl methylcellulose 
(HPMC K-4M) was obtained from Loba chemicals, Mumbai and Carbopol 934-P and Mannitol was obtained 
from S.D. Fine Chemicals, Mumbai. Magnesium stearate was obtained Signet Chemicals, Mumbai, India. All 
other ingredients were further used without purification of analytical grade. 
 
2.2 Experimental Methods 
2.2.1 Compatibility Studies 
2.2.1.1 FTIR Studies 
The drug-excipient compatibility studies were carried out using Fourier Transform Infrared Spectrophotometer 
(FTIR). Infrared spectra of pure drug and mixture of drug and excipients were recorded. A base line correction 
was made using dried potassium bromide and then the spectra of the drug mixture, drug polymer mixture, 
formulation mixture and potassium bromide were recorded on FTIR. 
2.2.1.2 Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry (DSC) was performed using Schimazdu DSC 60 instrument. The samples 
were hermatically sealed in aluminium pans and heated over the temperature range 35 
0
C to 300 
0
C with heating 
rate of  10 
0
C/min. The inert atmosphere was provided by purging nitrogen gas flowing at 10 ml/min.  
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2.2.2 Formulation of bioadhesive buccal tablets 
Buccal tablets containing aminophylline were prepared by direct compression method. The ingredients of the 
core layer were weighed accurately and mixed by trituration in a glass mortar and pestle for 15 minutes. All the 
ingredients were screened through the sieve no. 100. The above mixture was then compressed using 8 mm punch 
on 8 stages rotary tablet compression machine. In order to obtain constant tablet weight the Mannitol was added 
as filler excipient in the core layer. After compression of tablets, the upper punch was removed carefully without 
disturbing the set up and mixed ingredients.  
2.2.3 Evaluation of bioadhesive buccal tablets 
2.2.3.1 Weight Variation 
Eight tablets from each formulation (F1 to F8) were weighed using an electronic balance and the average weight 
was calculated. The weight variation test for all the formulations complies with the IP limit (± 10%).  
2.2.3.2 Hardness 
Tablets required certain amount of strength or hardness and resistance to friability, to withstand mechanical 
shocks of handling in manufacture, packaging and shipping. The hardness of the tablets was determined using 
Monsanto hardness tester. It is expressed in Kg/cm
2
. Three tablets were randomly picked from each formulation. 
(Singh & Ahuja, 2002). 
2.2.3.3 Friability 
Ten tablets were weighed (Wo) and placed in the Roche friabilator and was rotated at 25 rpm for 4 minutes. 
After revolutions, the tablets were dedusted and weighed again (W). The percentage friability was measured 
using the following formula. (Madgulkar & Pokharkar 2008). 
Percentage friability = 1- (W/Wo) ×100 
                                           Where, Wo = Initial weight of tablet 
                                                    W = Weight of tablets after revolution 
2.2.3.4 Thickness 
The thickness of three randomly selected tablets from each formulation was determined in mm using a vernier 
caliper. The average values were calculated. 
2.2.3.5 Determination of tablet swelling index 
Tablets were weighed (W1) and placed individually in Petri dishes containing 20 ml of distilled water. The 
dishes were stored at room temperature. After 30, 60, 120 and 240 min, the discs were removed and the excess 
water on their surface was carefully removed using filter paper. The swollen discs were reweighed (W2) and the 
index of swelling was calculated by the following formula:  (Boyapally & Douroumis 2010).  
Swelling index = W2 −W1/ W1 
2.2.3.6 Surface pH Study 
The tablet is allowed to swell by keeping it in contact with 1 mL of phosphate buffer (pH 6.8) for 2 hours at 
room temperature. The pH is determined by bringing the electrode into contact with the tablet surface and 
allowing to equilibrating for 1 minute .The experiment was repeated thrice and data. (Owens& Sakr 2005). 
2.2.3.7 Bioadhesion strength 
The in-vitro bioadhesive strength study was done and the results are shown in the Table 03. On the modified 
physical balance and measure the force (N) required detaching of the tablet. The bioadhesion characteristics 
were affected by concentration of the bioadhesive polymers. Increase in concentration of the polymer increases 
bioadhesive strength of formulation.  
2.2.3.8 Drug content 
The drug content is determined for obtaining the amount and percentage of drug retained in the dosage unit of 
particular tablet lot. It is done by assay on application of suitable analytical procedure that is developed initially 
meant to give the stated amount of percentage of active drug that the dosage unit comprises. The percentage of 
drug content should comply with the specification of stated amounts in the individual monographs in the 
pharmacopoeias by any suitable analytical procedure. The drug that belongs to reported in the monographs to 
have contains not less than 98.5 % and not more than the equivalent of 101.0 % as per USP of stated amount of 
the drug. 
2.2.3.9 In vitro drug release studies 
USP dissolution apparatus with paddle was used for the in vitro dissolution studies of bioadhesive tablets with a 
simple modification. A two-end open glass cylinder of 3 cm diameter and 10 cm length was taken. The prepared 
bioadhesive tablet was placed by applying a moderate pressure this was then tied to one end of the cylinder, 
taking care to place the tablet inside the cylinder. This cylinder was then placed on the surface of dissolution 
medium (900 ml of phosphate buffer pH 6.8) maintained at 37 ± 0.5 ◦C at 100 rpm for 8 h. At specified time 
intervals, 5 ml samples were withdrawn and immediately replaced with an equal quantity of fresh buffer.  The 
samples were filtered and analysed after appropriate dilution by UV spectrophotometry at 271 nm. 
2.2.4 Stability of buccal tablets 
Stability of buccal tablets was performed for optimized formulation in normal human saliva.  Human saliva was 
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collected from humans and filtered through filter paper. Buccal tablets were placed in distinct petridishes 
containing 5 mL of human saliva and placed in a temperature-controlled oven for 6 hr at 37°C ± 0.2°C. At 
regular time intervals (0, 2, 4, and 6 hr), the buccal tablets were examined for change in colour, surface area and 
integrity. The experiment was repeated in triplicate (n = 3). (Bhanja & Das2010).   
 
3.0 Result and Discussion: 
3.1 Compatibility studies 
3.1.1 FTIR Studies 
The incompatibility between the drug and excipients were studied by FTIR spectroscopy.  The results indicate 
that there was no chemical incompatibility between drug and excipients used in the formulation. (Figure 1) 
3.1.2 Differential Scanning Calorimetry (DSC)  
Thermogram of Aminophylline HPMC, carbopol gave only one endotherm peaks, which are close to their 
melting temperature indicating that mixing of the Aminophylline in the excipients. The physical mixture 
formulation showed peak with reduced intensity suggests decrease in crystallinity of pure Aminophylline. 
(Figure 2) 
 
3.2 Evaluation of bioadhesive buccal tablet 
3.2.1 Weight variation test 
Tablets were randomly selected from each batch and individually weighed using digital balance. The weight 
variation test was conducted for each batch of all formulations F1 to F8 as per I.P and the results are shown in 
(Table 2). The weight variation test for all the formulations complies with the IP limit (± 10%).   
3.2.2 Hardness test 
The adequate tablet hardness is necessary requisite for consumer acceptance and handling. The measured 
hardness of the tablets of each batch of all formulations i.e. F1 to F8 were ranged about 6.0 to 8 .0 Kg/cm2 and 
the results are shown in (Table 2). 
3.2.3 Friability test 
The friability test for all the formulations were done as per the standard procedure I.P. The results of the 
friability test were tabulated in (Table 2). The data indicates that the friability was less than 1% in all 
formulations ensuring that the tablets were mechanically stable. (Velmurugan &  Vinushitha2010). 
3.2.4 Thickness 
The thickness of the tablets was found to be almost uniform in all formulations F1 to F8. The thickness was 
found to be in the range of 4.0 to 5.0 mm. None of the formulations (F1 to F8) showed a deviation. Hence, it is 
concluded that all the formulations complied the thickness and the results are shown in (Table 2). 
3.2.5 Swelling Index 
Swelling index of all the formulations F1 to F8 was found to be 22.6 to 71.1, which is matched with reported 
values. Hence, it was shown in. (Table 3)  
3.2.6 Surface pH 
Surface pH of all the formulations F1 to F8 was found to be 6.2 to 6.8, which is well within the limit of 
acceptable salivary pH range of 6.2 to 6.9. Hence, it was concluded that all formulations could not produce any 
local irritation to the mucosal surface. (Table 3)  
3.2.7 Bioadhesive strength 
The in vitro bioadhesive strength study was performed and the results are shown in the (Table 3). On the 
modified physical balance and measure the force (N) required detaching the tablet. The bioadhesion 
characteristics were affected by the concentration of the bioadhesive polymers. Increase in concentration of 
polymer increases bioadhesive strength of formulation. The formulations (F1, F2, F3 & F4) with HPMCK4M 
and Mannitol showed the bioadhesive strengths of 29.5gm, 31.4gm, 34.5gm and 35.8gm respectively. The 
formulations (F5, F6, F7 & F8) with Carbopol 934p and Mannitol showed the bioadhesive strengths of, 27.6 gm., 
30.5gm, 32.5gm and 34.1gm respectively. (Figure 5)  
3.2.8 Drug content 
The drug content of each batch of all the formulations (F1 to F8) was evaluated as per the standard protocol. The 
results indicate that the percentage of drug content was found to be 98.00% to 101.00%. Hence it is concluded 
that all the formulations are following acceptable limits as per Indian Pharmacopoeia i.e. ± 5%. (Table 2) 
3.2.9 In Vitro release studies 
All the prepared buccal tablets were evaluated for the % cumulative drug release and drug release profile was 
shown in (figure 4). The formulation F4 release the drug near about 98.96 % at the end of 8 hrs this indicate that 
F4 formulation containing different polymer ratio could be fit for the Buccal tablet. So the drug release profile of 
formulation F4 was found Maximum at the end of 8 hrs. (Table 3)  
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3.3 Stability of buccal tablets 
At regular time intervals (0, 2, 4, and 6 hr), the buccal tablets were examined for change in colour (no change), 
surface area (8.11 to 8.39 mm) no Collapsing and thickness is 4-5 (Table 4)  
 
4. Conclusion 
Development of bioadhesive buccal drug delivery of Aminophylline is one of the alternative routes of 
administration. In this present study F4 formulation comprises of Aminophylline  and HPMC K4M (1:3) showed 
optimum drug release and satisfactory bioadhesive properties. Thus the study revealed that the Aminophylline 
buccal tablets showed good bioadhesion time with sustained release of drug for more than 8 hours. The 
optimized formulation also showed satisfactory surface pH and physical parameters satisfactory stability and 
comfortability in the oral cavity. From the results of present investigation it can be concluded that 
Aminophylline can certainly be administered through the oral mucosa and HPMC K4M is suitable for 
development of bioadhesive buccal system. 
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Table 1. Composition of Aminophylline bioadhesive buccal tablets. 
Formulation D : P Drug HPMC K4M Carbopol   
934P 
Mannitol Mg stearate 
F1 1:0.50 50mg   25mg       - 223mg 2mg 
F2 1:1 50 mg  50mg       - 198mg 2mg 
F3 1:2 50 mg 100mg       -    148mg 2mg 
F4 1:3 50 mg 150mg       -    98mg 2mg 
F5 1:0.50 50 mg  - 25mg 223mg 2mg 
F6 1:1 50 mg  - 50mg 198mg 2mg 
F7 1:2 50 mg    -  100mg 148mg 2mg 
F8 1:3 50 mg          - 150mg    98mg 2mg 
 
 
Table  2. Evaluation of Aminophylline bioadhesive buccal tablets 
Formulation Weight Variation 
(mg) 
Hardeness 
(Kg/cm
2
) 
Thickness 
(mm) 
   Friability 
(%) 
Drug 
Content(%)  
F1 300.4 ± 2.18 7.18 ± 0.15 4.49 ± 0.06 0.39 ± 0.05 98.42 
F2 298.1 ± 1.33 6.98 ± 0.18 4.44 ± 0.05 0.34 ± 0.15 98.89 
F3 300.1 ± 2.08 7.34 ± 0.16 4.48 ± 0.06 0.41 ± 0.08 98.99 
F4 298.4 ± 2.14 6.92 ± 0.19 4.54 ± 0.04 0.44 ± 0.13 99.43 
F5 300.1 ± 1.09 7.08 ± 0.29 4.47 ± 0.01 0.42 ± 0.08 98.96 
F6 298.3 ± 1.45 7.16 ± 0.15 4.52 ± 0.03 0.34 ± 0.22 98.99 
F7 299.4 ± 1.52 7.04 ± 0.23 4.45 ± 0.02 0.36 ± 0.05         98.81 
F8 299.3 ± 2.14 7.16 ± 0.15 4.49 ± 0.02 0.47 ± 0.05        99.40 
 
Table 3. Evaluation of Aminophylline bioadhesive buccal tablets 
Formulation  
Drug release 
(%) 
Bioadhesive 
Strength (gm) 
Surface 
 PH 
Swelling 
Index (%)  
F1 
83.96 ±1.61   
 
29.5 6.2 22.6 ± 1.9 
F2 85.36 ±1.20 31.4 6.8 27.7 ± 0.4 
F3 84.36 ±1.34 34.5 6.4 39.2 ± 1.3 
F4 98.96 ±1.00 35.8 6.2 31.8 ± 0.3 
F5 82.46 ±1.20 27.6  6.3 62.9 ± .83 
F6 78.65 ±1.49 30.5  6.7 71.1 ± 0.3 
F7 85.34 ±1.49 32.5 6.5 57.4 ± 1.7 
F8 81.35 ±1.61 34.1 6.2 29.3 ± 1.9 
 
Table 4. Stability data of buccal tablets in normal human saliva 
Time 
(hrs) 
Colour 
change 
Thickness (mm) Change in shape 
Diameter (mm) 
Collapsing 
0 No 4.54 ± 0.01 8.11 ± 0.01 No 
1 No 4.60 ± 0.01 8.19 ± 0.01 No 
2 No 4.71 ± 0.01 8.38 ± 0.01 No 
4 No 4.90 ± 0.01 8.39 ± 0.01 No 
6 No 4.94 ± 0.01 8.37 ± 0.01 No 
Food Science and Quality Management                                                                                                                                             www.iiste.org 
ISSN 2224-6088 (Paper)  ISSN 2225-0557 (Online) 
Vol.34, 2014 
 
39 
 
Figure 1. FTIR of pure Aminophylline (A),   Aminophylline + HPMC (B), Aminophylline + carbopol (C),    
Aminophylline + Mannitol (D), and Drug + all exciepients (E). 
 
 
Figure 2. DSC  of pure Aminophylline (A),  HPMC (B), carbopol (C),   Mannitol (D), and Drug + all exciepients 
(E). 
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Figure 3. Measurement of bioadhesive strength 
a- scale; b-glass vial; c-sheep buccal mucosa; d- bioadhesive tablet; 
e- Adjustable pan; g-weight 
 
 
Figure 4. In-vitro drug release profiles of formulations 
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Figure 5. Bioadhesive strength of all the formulation 
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